The Braves' ace, Chris Sale, is having a remarkable season, and it's making fans feel nostalgic for 2018. Sale, who turned 37 this year, is on a roll, boasting a 2.01 ERA, the fourth-best in the Majors and the best in the NL. He's been a force to be reckoned with, allowing two earned runs or fewer in 10 of his first 11 starts. This is a testament to his resilience and the team's strategy of giving him extra rest between starts, a tactic that seems to be paying off.
What makes Sale's performance even more impressive is his age. He's joining an elite group of pitchers who, at 37 or older, have managed to maintain a sub-2.00 ERA through the first 12 starts of a season since 2000. This includes legends like Roger Clemens, Justin Verlander, Tim Hudson, and Kenny Rogers. Sale's ability to stay dominant as he ages is a rare and awe-inspiring feat.
The Braves made a bold move by acquiring Sale from the Red Sox before the 2024 season, despite his injury history. But the risk has paid off. Sale's four-seamer, which averaged a blistering 97 mph in a recent game, is a testament to his continued dominance. This pitch's highest average velocity since 2019 further cements his status as a top-tier pitcher.
The extra rest between starts might be a significant factor in Sale's success. By giving him two extra days of rest, the Braves are allowing him to maintain his peak performance. This strategy is a strategic move that could be a game-changer for the team's success this season.
In my opinion, Sale's performance is a fascinating blend of age-defying resilience and strategic team management. It's a reminder that sometimes, taking a chance on an injured player can pay dividends. The Braves' decision to acquire Sale has been a masterstroke, and it's exciting to see him continue to dominate the mound. As a baseball fan, I can't help but feel a sense of nostalgia for the golden era of 2018, but with a twist of modern-day success.
